Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kala Pharmaceuticals Inc.

    NASDAQ: KALA · Real-Time Price · USD
    4.62
    -0.63 (-12.08%)
    At close: Jun 27, 2025, 3:59 PM
    4.48
    -2.86%
    After-hours: Jun 27, 2025, 05:27 PM EDT

    Kala Pharmaceuticals Statistics

    Share Statistics

    Kala Pharmaceuticals has 6.45M shares outstanding. The number of shares has increased by 116.27% in one year.

    Shares Outstanding

    n/a
    		 6.45M

    Shares Change (YoY)

    n/a
    		 116.27%

    Shares Change (QoQ)

    n/a
    		 32.13%

    Owned by Institutions (%)

    n/a
    		 73.7%

    Shares Floating

    n/a
    		 5.32M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,221

    FTD / Avg. Volume

    n/a
    		 1.89%

    Short Selling Information

    The latest short interest is 294.01K, so 4.56% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 294.01K

    Short % of Shares Out

    n/a
    		 4.56%

    Short % of Float

    n/a
    		 5.8%

    Short Ratio (days to cover)

    n/a
    		 8.25

    Valuation Ratios

    The PE ratio is -6.84 and the forward PE ratio is -1.25. Kala Pharmaceuticals's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -6.84

    Forward PE

    n/a
    		 -1.25

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 21.36

    P/FCF Ratio

    n/a
    		 -8.9

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Kala Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.11, with a Debt / Equity ratio of 2.62.

    Current Ratio

    n/a
    		 3.11

    Quick Ratio

    n/a
    		 3.11

    Debt / Equity

    n/a
    		 2.62

    Debt / EBITDA

    n/a
    		 -0.79

    Debt / FCF

    n/a
    		 -1.09

    Interest Coverage

    n/a
    		 -7.09

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,013,447.37

    Employee Count

    n/a
    		 38

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -17.98% in the last 52 weeks. The beta is -1.98, so Kala Pharmaceuticals's price volatility has been lower than the market average.

    Beta

    n/a
    		 -1.98

    52-Week Price Change

    n/a
    		 -17.98%

    50-Day Moving Average

    n/a
    		 3.84

    200-Day Moving Average

    n/a
    		 5.91

    Relative Strength Index (RSI)

    n/a
    		 68.82

    Average Volume (20 Days)

    n/a
    		 64,435

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -40.98M

    Net Income

    n/a
    		 -38.51M

    EBITDA

    n/a
    		 -40.98M

    EBIT

    n/a
    		 -44.29M

    Earnings Per Share (EPS)

    n/a
    		 -1.01
    Full Income Statement

    Balance Sheet

    The company has 51.18M in cash and 32.25M in debt, giving a net cash position of 18.93M.

    Cash & Cash Equivalents

    n/a
    		 51.18M

    Total Debt

    n/a
    		 32.25M

    Net Cash

    n/a
    		 18.93M

    Retained Earnings

    n/a
    		 -667.92M

    Total Assets

    n/a
    		 48.25M

    Working Capital

    n/a
    		 22.74M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -29.38M and capital expenditures -208K, giving a free cash flow of -29.59M.

    Operating Cash Flow

    n/a
    		 -29.38M

    Capital Expenditures

    n/a
    		 -208K

    Free Cash Flow

    n/a
    		 -29.59M

    FCF Per Share

    n/a
    		 -0.78
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    KALA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for KALA is $13.5, which is 155.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $13.5

    Price Target Difference

    n/a
    		 155.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 21, 2022. It was a backward split with a ratio of 1:50.

    Last Split Date

    n/a
    		 Oct 21, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:50

    Scores

    Altman Z-Score

    n/a
    		 -20.58

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist